Erythromycin

Product NDC: 52565-033
11-digit product format: 525650033
Labeler code: 52565
Product ID: 52565-033_f025369b-bbc2-4856-8fbb-19efd5aafbe3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Erythromycin
Dosage form: GEL
Route: TOPICAL
Labeler: Teligent Pharma, Inc.
Application: ANDA208154
Marketing category: ANDA
Marketing start: 2017-07-26
Marketing end: 0000-00-00
Substance: ERYTHROMYCIN
Active strength: 20 mg/g
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	52565-033		I	Inactivated by FDA	2026-09-14
excluded package	package	52565-033	52565-033-30	I	Inactivated by FDA	2026-09-14
excluded package	package	52565-033	52565-033-60	I	Inactivated by FDA	2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52565-033-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52565-033-60	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52565-033-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52565-033-60	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52565-033-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52565-033-60	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52565-033-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52565-033-60	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52565-033-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52565-033-60	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52565-033-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52565-033-60	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52565-033-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52565-033-60	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	52565-033-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	52565-033-60	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	52565-033-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	52565-033-60	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	52565-033-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	52565-033-60	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	52565-033-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	52565-033-60	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	52565-033-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	52565-033-60	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	52565-033-30	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	52565-033-60	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	52565-033-30	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	52565-033-60	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	52565-033-30	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	52565-033-60	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A208154-001	ERYTHROMYCIN	ERYTHROMYCIN	2%	GEL / TOPICAL			2017-07-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL		2017-07-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A208154-001	ERYTHROMYCIN	2%	GEL / TOPICAL	AT	2017-07-19	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A208154-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A208154-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A208154-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A208154-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A208154-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A208154-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A208154-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A208154-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A208154-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A208154-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A208154-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A208154-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A208154-001	AT	1	`ea99ee380514…`
2023-05-13 08:27 UTC	2023-05	A208154-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A208154-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A208154-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A208154-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A208154-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A208154-001	AT	1	`cb3db0bc1861…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab	Product name	3	20250717
3b331500-3b74-bd2b-fede-d46839f2f4d5	Product name	6	20240313
fdae2630-eae0-4769-abfd-8f33d5b771b4	Product name	3	20240202
8c898317-b543-1e4e-254f-84cec2f3f57e	Product name	2	20191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebe	Product name	2	20180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9	Product name	2	20170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
57850177-5927-151f-e1fa-7e2ca47f81e5	Product name	1	20140508
8ee71591-1d8f-e24e-242b-bfef131e3168	Product name	1	20140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3c	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52565-033-30	2023-01-30	C162847	48780-1	f386c649-fd9e-0266-e053-dadaa90a7c1a	Erythromycin Topical Gel USP, 2%
52565-033-60	2023-01-30	C162847	48780-1	f386c649-fd9e-0266-e053-dadaa90a7c1a	Erythromycin Topical Gel USP, 2%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52565-033-30	Erythromycin	1 in 1 CARTON	GEL	1	3
52565-033-30	Erythromycin	30 g in 1 TUBE	GEL	30	3
52565-033-60	Erythromycin	60 g in 1 TUBE	GEL	60	3
52565-033-60	Erythromycin	1 in 1 CARTON	GEL	1	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
52565-033-30	GM - Gram	52565-033	68f6c3b0-4906-47a4-bdc3-604e4d0548ee	1	2017-10-13
52565-033-60	GM - Gram	52565-033	5b447f9c-d3ad-418b-8e7c-08c1f0ec909f	1	2017-10-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52565-033	ERYTHROMYCIN (ERYTHROMYCIN) GEL [TELIGENT PHARMA, INC.]	3	Legacy NDC, 4 package rows	20191109_b21d02ea-5394-4f88-8d2b-3a8cd6e807a0.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
63937KV33D	ERYTHROMYCIN	114-07-8	ERYTHROMYCIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310152	erythromycin 2 % Topical Gel	PSN	b21d02ea-5394-4f88-8d2b-3a8cd6e807a0	3
310152	erythromycin 0.02 MG/MG Topical Gel	SCD	b21d02ea-5394-4f88-8d2b-3a8cd6e807a0	3
310152	erythromycin 2 % Topical Gel	SY	b21d02ea-5394-4f88-8d2b-3a8cd6e807a0	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
52565-033-30	52565003330	1 TUBE in 1 CARTON (52565-033-30) > 30 g in 1 TUBE	1 tube	2017-07-26	0000-00-00	No	No	Current
52565-033-60	52565003360	1 TUBE in 1 CARTON (52565-033-60) > 60 g in 1 TUBE	1 tube	2017-07-26	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Erythromycin Topical Gel USP, 2%	Teligent Pharma, Inc.	2017-07-26	HUMAN PRESCRIPTION DRUG LABEL	3